- Bevorzugter Name
- 2-Chlorobenzyl 5-(4-pyridinyl)-1,3,4-oxadiazol-2-yl sulfide
- IUPAC
- 2-[(2-chlorophenyl)methylsulfanyl]-5-pyridin-4-yl-1,3,4-oxadiazole
- Englischer Name
- 2-chlorobenzyl 5-(4-pyridinyl)-1,3,4-oxadiazol-2-yl sulfide
- Summenformel
- C14H10ClN3OS
- Molmasse
- 303.77
Namen und Synonyme
478482-74-5GSK3-IN-12-((2-Chlorobenzyl)thio)-5-(pyridin-4-yl)-1,3,4-oxadiazole2-chlorobenzyl 5-(4-pyridinyl)-1,3,4-oxadiazol-2-yl sulfideWAY-3527534-[5-[[(2-Chlorophenyl)methyl]thio]-1,3,4-oxadiazol-2-yl]pyridineMFCD04031734SMR0001485502-[(2-chlorophenyl)methylsulfanyl]-5-pyridin-4-yl-1,3,4-oxadiazole4-(5-{[(2-chlorophenyl)methyl]sulfanyl}-1,3,4-oxadiazol-2-yl)pyridineMLS000557834CHEMBL40004
Weitere Namen anzeigen
WAY-352753 (GSK3-IN-1)GSK3-IN-1, 10 mM in DMSOPyridine, 4-[5-[[(2-chlorophenyl)methyl]thio]-1,3,4-oxadiazol-2-yl]-synthase,GSK-3,inhibit,WAY 352753,Glycogen synthase kinase 3,WAY352753,Glycogen synthase kinase-3,Inhibitor,Diabetes,glycogen
BDBM8551cid_851256orb1297750orb1940129SCHEMBL5024085HMS2426M11EBC-06936HY-Q48328